2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Monotherapy: new trials by email Literature Review of Monotherapy trials Research Report on Monotherapy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Percutaneous Coronary Intervention Followed by Antiplatelet Monotherapy in the Setting of Acute Coronary Syndromes Antiplatelet Monotherapy - Acute Coronary Syndrome | Phase 3 | Completed | Hospital Israelita Albert Einstein | 3410 | 2020-10-15 | 2025-07-03 |
| Dabrafenib Plus Trametinib vs Vemurafenib Alone in Unresectable or Metastatic BRAF V600E/K Cutaneous Melanoma Dabrafenib, Vemurafenib, Trametinib - Melanoma | Phase 3 | Completed | Novartis Pharmaceuticals | 704 | 2012-06-04 | 2021-02-24 |
Acute Coronary Syndrome (1) · Melanoma (1) · Neoplasms (1)
Hospital Israelita Albert Einstein (1) · Novartis Pharmaceuticals (1)
Brazil (2) · Argentina (1) · Australia (1) · Austria (1) · Belgium (1) · Canada (1) · Czechia (1) · Denmark (1) · Finland (1) · France (1) · Germany (1) · Hungary (1) · Ireland (1) · Israel (1) · Italy (1)
PMID 25399551, PMID 26433819, PMID 27864013, PMID 31166680, PMID 34225229, PMID 40888723, PMID 41384891, PMID 42200630